Avastin helps Roche outpace the market again

April 16, 2009
Sales and Marketing Roche

Strong sales growth across all its business divisions, including prescription medicines has helped Roche outpace the market again in the …

Simponi approved in Canada

April 16, 2009
Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

Time to get your act together

April 15, 2009
Business Services recruitment, work life balance

I have a confession to make. Sometimes, when Im on a training course, I think I might be better off …

Covance expands in Latin America

April 15, 2009
Research and Development Covance, Peru, South America

Covance has opened new clinical development offices in Chile and Peru, and expanded its operations in Argentina to help serve …

Helsinn chooses Dublin for R&D investment

April 14, 2009
Research and Development Helsinn

Helsinn Birex Pharmaceuticals is to invest 13 million euros in a new pilot-scale R&D facility in Ireland, to help it …

Shire to close small molecule plant

April 14, 2009
Manufacturing and Production Shire

Shire Pharmaceuticals is shutting down a US production facility and will outsource the production to contract manufacturers DSM.The measure is …

Lilly’s ex-marketing chief joins Innovex

April 14, 2009
Business Services, Medical Communications, Sales and Marketing Innovex

Richard Pilnik, Lilly's head of marketing is to join contract sales organisation Innovex to serve as its president.Pilnik has 25 …

Committee approves limited use of Seroquel in depression

April 9, 2009
Research and Development, Sales and Marketing AZ, Seroquel, US

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …

Efient launched in the UK

April 9, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …

Boehringer Ingelheim takes the lead on Twitter

April 8, 2009
Medical Communications, Sales and Marketing Boehringer, Twitter, new media, social networking

The explosion in the popularity of Twitter is the latest buzz in online social networking, but most pharma companies are …

2-in-1: Merck and Schering-Plough

April 8, 2009
Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

Covance acquires early clinical development business in Switzerland

April 8, 2009
Research and Development Covance

Covance has expanded its presence in clinical pharmacology in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical …

Wyeth execs to lead on biotech in new Pfizer

April 8, 2009
Sales and Marketing MA, Pfizer

Pfizer has unveiled the new structure of the merged company created by its proposed acquisition of Wyeth. It plans to …

Top CROs can look forward to ‘five years of growth’

April 8, 2009
Research and Development CRO

The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …

Quintiles completes 400th trial using electronic data capture

April 7, 2009
Research and Development CRO, Quintiles

Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …

MEP animal testing vote angers welfare groups

April 7, 2009
Research and Development, Sales and Marketing Animal testing, Europe, preclinical

The European Parliament's Agriculture and Rural Development Committee has been accused of watering down proposals drawn up by the European …

A new approach to CRO partnerships

April 6, 2009
Research and Development Pfizer, UK, clincal, partnerships

Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009
Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …

Med comms ‘needs to be more transparent’

April 6, 2009
Medical Communications Liberation

There needs to be greater transparency in medical communications if negative views of the pharma sector are to be countered, …

The Gateway to Local Adoption Series

Latest content